Nexalin Technology News

Nexalin Technology Has Received A Notice Of Allowance For Its U.S. Patent Application 18/342,590 Titled "Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) Method For Alzheimers And Dementia"

Nexalin Technology Has Received A Notice Of Allowance For Its U.S. Patent Application 18/342,590 Titled "Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) Method For Alzheimers And

BenzingaApr 30 13:03 ET

Express News | Nexalin Technology Regains Compliance With Nasdaq Continued Listing Requirements

ReutersApr 25 10:44 ET

Predictive Oncology, BIMI Holdings, IMAC Holdings Among Healthcare Movers

Seeking AlphaApr 19 10:00 ET

LI, VERU and MRIN Among Pre-market Losers

Seeking AlphaApr 19 08:16 ET

12 Health Care Stocks Moving In Friday's Pre-Market Session

GainersChromocell Therapeutics (AMEX:CHRO) stock increased by 21.6% to $1.49 during Friday's pre-market session. The company's market cap stands at $8.7 million. Kineta (NASDAQ:KA) stock moved upwards

BenzingaApr 19 08:08 ET

Lexaria Bioscience, Biosig Technologies, BIMI Holdings Among Healthcare Movers

Seeking AlphaApr 17 10:00 ET

JAGX, BSGM and SXTC Among Mid-day Movers

Seeking AlphaApr 16 12:40 ET

Nexalin Technology Files to Offer Common Stock Worth $5.65M

Seeking AlphaApr 16 11:30 ET

Palisade Bio, Marinus Pharmaceuticals, Poseida Therapeutics Among Healthcare Movers

Seeking AlphaApr 16 10:00 ET

Molecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals Among Healthcare Movers

Seeking AlphaApr 9 10:00 ET

Express News | Nexalin Technology Accelerates HALO Clarity Manufacturing; Expects To Produce ~500 Units In Q3 2024

Moomoo 24/7Apr 9 08:45 ET

Nexalin Technology Accelerates Manufacturing of Its HALO Clarity Following Successful Usability, Feasibility, and Electrical Testing

Mark White, CEO of Nexalin Technology, stated, "I am thrilled to report that the HALOClarity passed a series of rigorous tests, validating our manufacturing process and illustrating that our device meets the highest product standards.

GlobeNewswireApr 9 08:30 ET

12 Health Care Stocks Moving In Monday's After-Market Session

GainersKineta (NASDAQ:KA) shares increased by 24.3% to $0.67 during Monday's after-market session. The market value of their outstanding shares is at $7.3 million. Moleculin Biotech (NASDAQ:MBRX) stoc

BenzingaApr 8 16:31 ET

PERI, ITRM and CADL Among Pre-market Losers

Seeking AlphaApr 8 08:23 ET

Check-Cap, Outset Medical, Vincerx Pharma Among Healthcare Movers

Seeking AlphaApr 5 10:01 ET

Nexalin Technology Awarded Key Patent Related To Gen-3 HALO Clarity

Mark White, CEO of Nexalin Technology, stated, "This method of use patent award marks a major achievement for the Company and follows another recent patent covering our core technology. These patents

BenzingaApr 4 13:12 ET

Nexalin Technology Awarded Key Patent Related to Its Gen-3 HALO Clarity, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device

Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office (USPTO) has awarded U.S. Patent No. 17/337,653 relating to the Company's non-invasive, frequency-based deep brain stimulation device.

GlobeNewswireApr 4 13:00 ET

Nexalin Technology Unveils Positive Results of Clinical Study for Gen-2 TACS Device

Yahoo FinanceApr 4 11:05 ET

FibroGen, Acorda Therapeutics, Enveric Biosciences Among Healthcare Movers

Seeking AlphaApr 3 10:00 ET

Nexalin Technology Unveils Positive Results of Clinical Study for Gen-2 TACS Device | NASDAQ:NXL

Proactive InvestorsApr 3 09:10 ET